Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riociguat (Adempas) Postmarketing Safety Study in Pulmonary Hypertension in China
CTR20171218Phase 4Completed
- Sponsor
- ---
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of riociguat in pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary hypertension (CTEPH), sponsored by ---. Started Dec 2018; status: completed.
02
Drugs
riociguat
03
Conditions
pulmonary arterial hypertension (PAH)chronic thromboembolic pulmonary hypertension (CTEPH)
Beyond the preview
Go deeper on CTR20171218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171218.